Efficacy and Safety of Azacytidine in combination with fludarabine and high-dose cytarabine with G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2021.07.019 ◽

2021 ◽

Author(s):

Ibraheem H. Motabi ◽

Shaima M. Al Aoun ◽

Maged Al-Ammari ◽

Belal M. Albtoosh ◽

Shahid Iqbal ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

High Dose ◽

Efficacy And Safety ◽

Open Label ◽

High Dose Cytarabine ◽

Open Label Phase ◽

Refractory Acute Myeloid Leukemia ◽

Acute Myeloid

Download Full-text

AML-149: Efficacy and Safety of Azacytidine in Combination with Fludarabine and High-Dose Cytarabine with G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Open-Label, Phase II Study

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01682-7 ◽

2021 ◽

Vol 21 ◽

pp. S284

Author(s):

Shaima Al Aoun ◽

Ibraheem Motabi ◽

Maged Al Ammari ◽

Nawal Al lshehry ◽

Mohammed Marei ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

High Dose ◽

Efficacy And Safety ◽

Open Label ◽

High Dose Cytarabine ◽

Open Label Phase ◽

Refractory Acute Myeloid Leukemia ◽

Acute Myeloid

Download Full-text

Poster: AML-149: Efficacy and Safety of Azacytidine in Combination with Fludarabine and High-Dose Cytarabine with G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Open-Label, Phase II Study

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01327-6 ◽

2021 ◽

Vol 21 ◽

pp. S212

Author(s):

Shaima Al Aoun ◽

Ibraheem Motabi ◽

Maged Al Ammari ◽

Nawal Al lshehry ◽

Mohammed Marei ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

High Dose ◽

Efficacy And Safety ◽

Open Label ◽

High Dose Cytarabine ◽

Open Label Phase ◽

Refractory Acute Myeloid Leukemia ◽

Acute Myeloid

Download Full-text

PF261 A RANDOMIZED, OPEN-LABEL, PHASE II STUDY OF SELINEXOR VERSUS PHYSICIAN'S CHOICE (PC) IN OLDER PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

HemaSphere ◽

10.1097/01.hs9.0000559256.03686.3a ◽

2019 ◽

Vol 3 (S1) ◽

pp. 82-83 ◽

Cited By ~ 1

Author(s):

K. Sweet ◽

W. Blum ◽

H. Donner ◽

I. Flinn ◽

O. Frankfurt ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Older Patients ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Open Label ◽

Open Label Phase ◽

Refractory Acute Myeloid Leukemia ◽

Acute Myeloid

Download Full-text

A 2:1 randomized, open-label, phase II study of selinexor vs. physician’s choice in older patients with relapsed or refractory acute myeloid leukemia

Leukemia & Lymphoma ◽

10.1080/10428194.2021.1950706 ◽

2021 ◽

pp. 1-12

Author(s):

Kendra Sweet ◽

Bhavana Bhatnagar ◽

Hartmut Döhner ◽

Will Donnellan ◽

Olga Frankfurt ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Older Patients ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Open Label ◽

Open Label Phase ◽

Refractory Acute Myeloid Leukemia ◽

Acute Myeloid

Download Full-text

Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia

International Journal of Hematology ◽

10.1007/s12185-019-02606-0 ◽

2019 ◽

Vol 109 (4) ◽

pp. 418-425

Author(s):

Nahoko Hatsumi ◽

◽

Shuichi Miyawaki ◽

Takahiro Yamauchi ◽

Akihiro Takeshita ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

High Dose ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

High Dose Cytarabine ◽

Refractory Acute Myeloid Leukemia ◽

Stimulating Factor ◽

Acute Myeloid

Download Full-text

Efficacy and safety of quizartinib in Japanese patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia in an open-label, phase 2 study

International Journal of Hematology ◽

10.1007/s12185-019-02727-6 ◽

2019 ◽

Vol 110 (6) ◽

pp. 665-674 ◽

Cited By ~ 3

Author(s):

Takeshi Takahashi ◽

Kensuke Usuki ◽

Kosei Matsue ◽

Hitoshi Ohno ◽

Toru Sakura ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Japanese Patients ◽

Phase 2 ◽

Efficacy And Safety ◽

Open Label ◽

Phase 2 Study ◽

Open Label Phase ◽

Refractory Acute Myeloid Leukemia ◽

Acute Myeloid

Download Full-text

Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

Cancer Discovery ◽

10.1158/2159-8290.cd-18-0774 ◽

2018 ◽

Vol 9 (3) ◽

pp. 370-383 ◽

Cited By ~ 90

Author(s):

Naval Daver ◽

Guillermo Garcia-Manero ◽

Sreyashi Basu ◽

Prajwal C. Boddu ◽

Mansour Alfayez ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Open Label ◽

Open Label Phase ◽

Refractory Acute Myeloid Leukemia ◽

Acute Myeloid

Download Full-text

Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms

Haematologica ◽

10.3324/haematol.2018.204792 ◽

2018 ◽

Vol 104 (4) ◽

pp. e143-e146 ◽

Cited By ~ 6

Author(s):

Anna B. Halpern ◽

Megan Othus ◽

Emily M. Huebner ◽

Bart L. Scott ◽

Paul C. Hendrie ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase I ◽

Myeloid Leukemia ◽

High Dose ◽

High Grade ◽

Myeloid Neoplasms ◽

High Dose Cytarabine ◽

Refractory Acute Myeloid Leukemia ◽

Acute Myeloid

Download Full-text

PF271 USING NEXT-GENERATION SEQUENCING TO PREDICT RESPONSE TO SALVAGE CHEMOTHERAPY WITH HIGH DOSE CYTARABINE AND MITOXANTRONE IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA PATIENTS

HemaSphere ◽

10.1097/01.hs9.0000559296.13095.e4 ◽

2019 ◽

Vol 3 (S1) ◽

pp. 87

Author(s):

J. Canaani ◽

M. Nagar-Marciano ◽

A. Shimoni ◽

I. Danilesko ◽

R. Yerushalmi ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Next Generation Sequencing ◽

Myeloid Leukemia ◽

Salvage Chemotherapy ◽

High Dose ◽

Next Generation ◽

High Dose Cytarabine ◽

Refractory Acute Myeloid Leukemia ◽

Generation Sequencing ◽

Acute Myeloid

Download Full-text

Very High Dose Cytarabine as Salvage Therapy for Relapsed or Refractory Acute Myeloid Leukemia in the Setting of Intensified Anthracycline Induction and Post Stem-Cell Transplantation

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2015.04.028 ◽

2015 ◽

Vol 15 ◽

pp. S184

Author(s):

Gilad Itchaki ◽

Ofir Wolach ◽

Michal Bar-Natan ◽

Moshe Yeshurun ◽

Ron Ram ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Salvage Therapy ◽

Myeloid Leukemia ◽

High Dose ◽

High Dose Cytarabine ◽

Refractory Acute Myeloid Leukemia ◽

Very High ◽

Acute Myeloid

Download Full-text